A Concept of Research on change in Inflammatory Markers in patients of Aamwata (w. s. r., Rheumatoid Arthritis) treated with Leech Therapy
Keywords:
Aamvata, Leech Therapy, Inflammatory Markers, Musculoskeletal disorders, CellulitisAbstract
Amavata can be correlated to Rheumatoid Arthritis which is characterized by the inflammatory type of arthritis, of severe and debilitating nature. No doubt modern medical science has got an important role to play in overcoming the agony of pain, restricted movement and disability and prolonged use of modern medicines are not only giving rise to many side effects, toxic symptoms and adverse reactions but also more serious complications are caused, Hence the management of this disease is merely insufficient in other systems of medicine and patients are continuously looking with a hope towards Ayurveda to overcome this challenge. Leech Therapy has been established as one of the most efficacious therapies in the management of various skin conditions like psoriasis, Eczema, cysts, abscess, and cellulitis etc. and musculoskeletal disorders. The present study primarily aims at studying the change in inflammatory markers such as C reactive proteins (CRP), Erythrocyte Sedimentation Rate (ESR), TLC (total leukocyte count), and DLC (differential leucocyte count) in two groups of patients of Aamvata. From numerous researches, it is evident that CRP, ESR, TLC, and DLC are important inflammatory markers and found to increase in various conditions like Rheumatoid Arthritis, Myocardial Infarction, Alzheimer’s Disease, Diabetes Mellitus, and other diseases where there is the inflammatory process in the body. . The present study aims at determining the changes in inflammatory markers like CRP, ESR, TLC, and DLC in the patients of Aamvata treated with Leech Therapy.
Downloads
References
2. RA –FAQ”s www.fifhtRA.or Diseases and conditons- RA www.rheumatology.org
3. RA, medicine,diet,treatment - www.medicinenet.com
4. RA, Wikipedia, the free encyclopedia
5. www.leechinghistoryinindia.com
6. www.Leechmeknow.com – cited on 29/06/16.
7. Markers of inflammation and cardio vascular disease- American heart association- circulation - Aha journals.
8. Inflammatory markers elevated in Patients with stable pain- Fran Lonery – Sept. 30, 2013
9. Medscape - Medical news from the American Academy of pain Management (AAPM) 24th Annual clinical meeting.
10. Inflammatory markers may predict Alcohol dependence – December.10, 2014
11. Deporeh Brauser Medscape Medical News from the American Academy of Addiction psychiatry (AAAP) – 25th Annual Meeting.
12. Inflammatory Markers and Risk of Type 2 Diabetes – A systematic Review and metaanalysis - Xia wang – American Diabetes Association 2013
13. Clinical Utility of inflammatory markers and advanced lipoprotein testing – advice from an expert panel of lipid specialists- Journals of clinical lipideology (2011) 5, 338-367
14. Michal H. Davidson, C-reactive proteins / Definition of CRP- Medical dictionary / Thesaurns, Acronyms, Encyclopaedia, Wikipedia, cited on 9/11/12.
15. Emerging inflammatory markers for assuring coronary heart disease risk – Carson MA et el. US National library of Medicine NIH. Current guidelines on CRP-…. testing – DHA & ACC New recommendations
16. Agnivesha, Revised by Charaka and Dhradabala; Charaka Samhita; 4th Ed, Varanasi; Chaukhambha orientalia publishers ,Chikitsa sthana12/52 Emedicine.medscape.com cited on 24/03/16
17. Management of Diabetic foot ulcer with Leech Therapy- A minimal invasive procedure. Dwiwedi Amarprekash et al.
18. Leech Therapy the healing art-www.amazing leeches.com
19. Medicinal leeches, historical use, ecology, genetics, Bio one www.bioone.org/doi/abs/10,1608, FR,1,4, cited on 24/12/16
20. Raval H.N. and Thakar A.B., Role of Raktamokshana by Jalloukavacharana and Siravedhana in the management of Vicharchika(eczema),Journal AYU,2012,33(1), 68-72.
21. Sushruta Samhita, K.R.Shrikantha Murthy, 2014, Chaukhamba Orientalia Publishers, Sutrasthana 13-3.
22. Agnivesha, Revised by Charaka and Dhradabala; Charaka Samhita; 4th Ed, Varanasi; Chaukhambha orientalia publishers Chikitsa sthana 16/61
23. Agnivesha, Revised by Charaka and Dhradabala; Charaka Samhita; 4th Ed, Varanasi; Chaukhambha orientalia publishers, Chikitsa sthana16/63
24. Madhavakara; Madhava Nidana; with Madhukosha Sanskrit commentary by Vijayarakshita and Srikanthadatta; with Vidyittini Hindi commentary by Sudarshan shastri Part-II; 30th Ed, Edited by Yadunandan Upadhyaya; Varanasi, Chaukhambha orientalia publishers; 2001; Pp 508, Madhava Nidana 25
25. Atharva ved 10/12/13
26. Wikipedia the free encyclopedia on history of rheumatism cited on 20/06/16
27. Yogaratnakara, with Hindi commentary by Indradeva Tripathi; 1st Ed; Krishnadas Academy; 1998; Pp -894,Pg No- 604, poorvardha (Shopha Nidana).
28. Sushruta Samhita, K.R.Shrikantha Murthy, 2014, Chaukhamba Orientalia Publishers ,sutra sthana, Chapter14, verse 25.
29. Charaka Samhita, Editor and Translator Priyavrat Sharma, 2014, Chaukhamba Orientalia Publishers,Sutrasthana, Chapter 24, verse 39.
30. Ashtanga Hridaya with commentary of Sarvangasundara of Arunadatta and Ayurveda rasayana of Hemadri, 7th Ed, Edited by Anna Moreshwar Kunte and Krishna shastri Navare; Varanasi; Chaukhambha orientalia publishers;; Sutrasthana, chapter16, verse 37. .
31. Sushruta Samhita, K.R. Shrikantha Murthy, 2014, Chaukhamba Orientalia Publishers, sutra sthana, Chapter13, verse 9.
32. Panchakarma Sangraha M.K. Shamkuwar, chapter 8, pg no 370.
33. Davidsons Principles and Practise of Medicine
34. Basic Pathology by Kumar, Cotran, Robins,Cellulitis,Prism Publishers,2000,
35. Making sense of inflammatory markers-http//www.rcpa.edu.au cited on 24/3/16
36. Cellulitis-wikipedia.org, mesh-doo2481,e-medicine,speciality infectious diseases, Medline plus.
37. Paracetamol uses,emedicine medscape.com, cited on 24/03/16
38. Srinivas Acharya, Panchakarma illustrated, Jalloukavacharana, Delhi (India), Chaukhamba Sanskrit Pratishthan,2006,pg no 429
39. A Conceptual overview on Inflammatory markers in patients of Vranashopha (Cellulitis) and its management with Leech Therapy, International Journal of Innovative Pharmaceutical Sciences and Research-IJIPSR,Vol-4,issue 1, pg15to 28, International, 2016,
Downloads
Published
How to Cite
Issue
Section
License
I declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein. All agreed to the terms and conditions, Privacy Policy, which is declared on Journal Website http://www.ayurline.in and online filled (uploaded) form.
Please read following declaration cum Agreement Carefully.:
I declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein.
I (We) agree (on behalf of me and my co-authors) to the following:
1- I (we) hereby assign to the publisher of the journal. Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) the right to (Electronically and print) publish on website www.ayurline.in and distribute the said manuscript and to create a derivative print work from the said manuscript. The assignment shall be effective so long as the manuscript is available on online networks.
2- I (we) shall remain the owner of the copyright in said manuscript. I (we) may publish the manuscript in any other journal or medium but such publication must include the notice that the manuscript was first published by Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) Journals including reference to the corresponding issue.
3- I (we) agree to hold the publisher of the Journal, Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) harmless for any unauthorized use of the paper by the journal subscribers.
4- I (we) confirm that I (we) have obtained all the necessary all permissions to include in the paper items such as quotations, figures, and the results of government-sponsored research/private or individual publishers/owners.
5- I (we) enclose where necessary written permission of authors and publishers to use any copyright material (previously published figures and tables).
6- I (we) confirm that after the publication of my (our) manuscript in Ayurline: International Journal of Research in Indian Medicine (IJ-RIM), the publisher has the sole authority of the paper/Research Article. The publisher has the authority to use the content of the whole paper or part of it, in an edited book, or other mediums or withdraw (unpublish) the article without the permission of authors.
8- If I / We found victims of plagiarism, (साहित्यिक चोरी) (e.g. text, images, videos etc.) I/ We sole responsible for such legal matters. I/We also declared that the Chief Editor/Publisher, Editorial Board of this Ayurline: International Journal of Research in Indian Medicine (IJ-RIM) Journal does not have any responsibility for plagiarism. Publisher shall not become any party in any legal matter and if any case is filed in court against plagiarisms or any copyright-related issues all expenses/Penalties should be paid/borne by me/we (Authors). I shall be obliged to pay all the costs of the court case if any happened in future.
7 -I voluntarily agreed to pay the necessary non-refundable evaluation fees of the my article, which are not the publication Charges.
8 - All disputes subject to Kurla, Mumbai court jurisdiction. This Copyright Licensing Agreement comes into force the day of sending this completed electronic form.